[HTML][HTML] Virus-like particle vaccinology, from bench to bedside

MO Mohsen, MF Bachmann - Cellular & molecular immunology, 2022 - nature.com
Virus-like particles (VLPs) have become key tools in biology, medicine and even
engineering. After their initial use to resolve viral structures at the atomic level, VLPs were …

[HTML][HTML] Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective

N Ebrahimi, Z Yousefi, G Khosravi, FE Malayeri… - Frontiers in …, 2023 - frontiersin.org
Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health
problems like genital warts and cancer. The national immunization schedules for individuals …

[HTML][HTML] Heparan sulfate and sialic acid in viral attachment: Two sides of the same coin?

IE Ramos-Martínez, E Ramos-Martínez… - International Journal of …, 2022 - mdpi.com
Sialic acids and heparan sulfates make up the outermost part of the cell membrane and the
extracellular matrix. Both structures are characterized by being negatively charged, serving …

[HTML][HTML] Navigating therapeutic strategies: HPV classification in head and neck cancer

H Tabatabaeian, Y Bai, R Huang, A Chaurasia… - British Journal of …, 2024 - nature.com
Abstract The World Health Organisation recognised human papillomavirus (HPV) as the
cause of multiple cancers, including head and neck cancers. HPV is a double-stranded DNA …

[HTML][HTML] Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?

G Milano, G Guarducci, N Nante, E Montomoli, I Manini - Vaccines, 2023 - mdpi.com
Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …

[HTML][HTML] Human papilloma virus: an unraveled enigma of universal burden of malignancies

I Khan, R Harshithkumar, A More, A Mukherjee - Pathogens, 2023 - mdpi.com
HPV, or Human Papilloma Virus, has been the primary causative agent of genital warts and
cervical cancer worldwide. It is a sexually transmitted infection mainly affecting women of …

[HTML][HTML] Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review

K Devaraja, S Aggarwal, M Singh - Vaccines, 2023 - mdpi.com
Therapeutic vaccination is one of the most effective immunotherapeutic approaches, second
only to immune checkpoint inhibitors (ICIs), which have already been approved for clinical …

Current Status of Human Papillomavirus–Targeted Therapies Development in Head and Neck Cancer

JC Park, B Bertaux, J Park, S Park - JCO Precision Oncology, 2023 - ascopubs.org
PURPOSE While the incidence of smoking-related head and neck squamous cell carcinoma
(HNSCC) has been declining, that of human papillomavirus (HPV)–mediated HNSCC has …

[HTML][HTML] Sleep deprivation and NLRP3 inflammasome: Is there a causal relationship?

M Amini, Z Yousefi, SS Ghafori… - Frontiers in …, 2022 - frontiersin.org
In the modern era, sleep deprivation (SD) is one of the most common health problems that
has a profound influence on an individual's quality of life and overall health. Studies have …

Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies

J Wang, L Ma, Y Chen, R Zhou, Q Wang… - Life Science …, 2024 - life-science-alliance.org
Human papillomavirus (HPV) infections account for several human cancers. There is an
urgent need to develop therapeutic vaccines for targeting preexisting high-risk HPV (such as …